Stock Analysis

VYNE THERAPEUTICS INC (VYNE)

Loading... + Investors. Track Smart Money conviction in VYNE. See who's accumulating, reducing, or initiating positions.

Loading...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +4
Streak
1Q ▲
Buyers last Q
64%

Smart Money Signals — VYNE

Based on 32 hedge funds · latest filing: 2025 Q4 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds added this stock than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term trade.
📊

High ownership — 80% of 3.0Y peak

80% of all-time peak
32 funds currently hold this stock — 80% of the 3.0-year high of 40 funds (reached 2025 Q2). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
〰️

Stable — ownership unchanged year-over-year

fund count last 6Q
The number of hedge funds holding this stock is almost the same as a year ago (+1 funds, +3% change). No significant rush to buy or sell — the institutional base is holding steady.
🟢

More buyers than sellers — 64% buying

18 buying10 selling
Last quarter: 18 funds were net buyers (7 opened a brand new position + 11 added to an existing one). Only 10 were sellers (7 trimmed + 3 sold completely). A clear majority buying is a strong confirmation signal.
➡️

Steady new buyers — ~7 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 7 → 13 → 7 → 7. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
📌

Mixed — 34% long-term, 41% new

34% conviction (2yr+) 25% medium 41% new
Of the 32 current holders: 11 (34%) held >2 years, 8 held 1–2 years, and 13 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
💰

Value +198% but shares only +72% — price-driven

Value
+198%
Shares
+72%
Last quarter: the total dollar value of institutional holdings rose +198%, but actual share count only changed +72%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
📊

Peak discovery — momentum slowing

9 → 7 → 13 → 7 → 7 new funds/Q
New funds entering each quarter: 7 → 13 → 7 → 7. The stock is well-known in the hedge fund world but new entries are declining. The easy phase of institutional discovery may be behind us.
📊

Mixed cohorts — 34% veterans, 50% new entrants

34% veterans 16% 1-2yr 50% new
Of 32 current holders: 11 (34%) held 2+ years, 5 held 1–2 years, 16 (50%) entered in the past year. Balanced distribution — some institutional memory, some recent momentum buyers.

Strong quality — 25% from major AUM funds

25% from top-100 AUM funds
8 of 32 current holders rank in the top 100 by AUM. A meaningful share of the ownership base comes from the most well-resourced institutions.
3.0
out of 10
Low Exit Risk
Exit risk score 3.0/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Hedge Fund Ownership: VYNE

How many hedge funds hold VYNE — quarterly history vs. share price
Quarterly hedge fund ownership of VYNE vs. share price

Market Analysis: VYNE

View More

Analyst Price Targets

-- Low
-- High
-- Average
-- Current

Analyst Recommendations

Stock Performance

Real-time

Company Profile: VYNE

-- --
Hedge Fund Positioning: VYNE
Loading... + Investors

Track Smart Money conviction in VYNE. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2025 Q4) Prior (2025 Q3) Change

Statistics: VYNE

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --
Institutional Holders (2025 Q4)
Loading... + investors

Track Smart Money conviction in VYNE. See who's accumulating, reducing, or initiating positions.

Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy
Price
13F Score™ 3Y / 7Y Shares Mkt Value Change Change % Source Quarter Filed